[Pubmed] Acute onset ocular myasthenia gravis after vaccination with the Oxford-AstraZeneca COVID-19 vaccine
Posté : 02 mai 2022 12:00
Orbit. 2022 May 2:1-5. doi: 10.1080/01676830.2022.2062777. Online ahead of print.
ABSTRACT
Myasthenia gravis (MG) is an autoimmune disease that results in muscle weakness and fatigability. Extraocular involvement may be the first sign of disease. It may be triggered by infections, stress, or medications. We describe a first reported case of ocular MG induced by the viral vector Oxford-AstraZeneca coronavirus disease (COVID-19) vaccine, detail the pathophysiology of vaccine-induced MG, and explore the impact of COVID-19 on MG patients.
PMID:35499172 | DOI:10.1080/01676830.2022.2062777
Source: https://pubmed.ncbi.nlm.nih.gov/3549917 ... 6&v=2.17.6